Acne vulgaris
Conditions
Interventions
The treatment with medicine for external use with Oral Administration of keishibukuryogankayokuinin(2.5g t.i.d before meals)for 12 weeks.
Sponsors
Shinjuku Minamiguchi Dermatology Skin Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Patients who have inflammatory of acne lesions more than 6 counts on one side of their faces. 2)Patients for whom oral administration was possible. 3)Patients who agreed with their written informed consent
Exclusion criteria
Exclusion criteria: 1)Patients with serious complications (liver,kidney,heart,blood,or metabolic disorders) 2)Steroid acne,Drug-induced acne, Necrotizing acne, Occupational acne. 3)Patients who administrated steroid drugs on their whole body. 4)Women who are pregnant, might be pregnamt or lactating or planning a pregnancy. 5)Patients who received drugs prohibited for concomitant use within 1 week before the registration of this study. 6)Patients who participated in clinical trial within 1 month before the registration of this study. 7)Patients taking or planning chemical treatment or laser treatment in this study period. 8)Patients with history of hypersensitivity to traditional Japanese medicine. 9)Patients considered inappropriate by the study investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The decrement of inflammatory of acne lesions The decrement of non-inflammatory of acne lesions Patients QOL(SKINDEX-16,Syndromes presenting indefinite complaints) Patients satisfaction(Visual analog scale) | — |
Countries
Japan
Contacts
Public ContactToshitatsu Nogita
Shinjuku Minamiguchi Dermatology Skin Clinic Director
Outcome results
None listed